vs
Side-by-side financial comparison of Devon Energy (DVN) and Stryker Corporation (SYK). Click either name above to swap in a different company.
Stryker Corporation is the larger business by last-quarter revenue ($7.2B vs $3.9B, roughly 1.8× Devon Energy). Devon Energy runs the higher net margin — 14.3% vs 11.8%, a 2.4% gap on every dollar of revenue. On growth, Stryker Corporation posted the faster year-over-year revenue change (11.4% vs -12.3%). Stryker Corporation produced more free cash flow last quarter ($1.9B vs $702.0M). Over the past eight quarters, Stryker Corporation's revenue compounded faster (16.9% CAGR vs 2.6%).
Devon Energy Corporation is an American company engaged in hydrocarbon exploration. It is organized in Delaware with operational headquarters in the 50-story Devon Energy Center in Oklahoma City, Oklahoma. Its operations are in the Delaware Basin, Eagle Ford Group, and the Rocky Mountains.
The Stryker is a family of eight-wheeled armored fighting vehicles derived from the Canadian LAV III, which in turn derived from the Swiss Mowag Piranha. Stryker vehicles are produced by General Dynamics Land Systems-Canada (GDLS-C) for the United States Army in a plant in London, Ontario. It has four-wheel drive (8×4) and can be switched to all-wheel drive (8×8).
DVN vs SYK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.9B | $7.2B |
| Net Profit | $562.0M | $849.0M |
| Gross Margin | — | 64.5% |
| Operating Margin | 19.0% | 25.2% |
| Net Margin | 14.3% | 11.8% |
| Revenue YoY | -12.3% | 11.4% |
| Net Profit YoY | -12.1% | 55.5% |
| EPS (diluted) | $0.90 | $2.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.9B | $7.2B | ||
| Q3 25 | $4.3B | $6.1B | ||
| Q2 25 | $4.0B | $6.0B | ||
| Q1 25 | $4.5B | $5.9B | ||
| Q4 24 | $4.5B | $6.4B | ||
| Q3 24 | $3.8B | $5.5B | ||
| Q2 24 | $3.9B | $5.4B | ||
| Q1 24 | $3.7B | $5.2B |
| Q4 25 | $562.0M | $849.0M | ||
| Q3 25 | $687.0M | $859.0M | ||
| Q2 25 | $899.0M | $884.0M | ||
| Q1 25 | $494.0M | $654.0M | ||
| Q4 24 | $639.0M | $546.0M | ||
| Q3 24 | $812.0M | $834.0M | ||
| Q2 24 | $844.0M | $825.0M | ||
| Q1 24 | $596.0M | $788.0M |
| Q4 25 | — | 64.5% | ||
| Q3 25 | — | 63.6% | ||
| Q2 25 | — | 63.8% | ||
| Q1 25 | — | 63.8% | ||
| Q4 24 | — | 64.9% | ||
| Q3 24 | — | 64.0% | ||
| Q2 24 | — | 63.0% | ||
| Q1 24 | — | 63.6% |
| Q4 25 | 19.0% | 25.2% | ||
| Q3 25 | 21.5% | 18.7% | ||
| Q2 25 | 28.7% | 18.5% | ||
| Q1 25 | 14.2% | 14.3% | ||
| Q4 24 | 18.7% | 9.0% | ||
| Q3 24 | 28.0% | 19.7% | ||
| Q2 24 | 26.7% | 19.4% | ||
| Q1 24 | 20.5% | 18.5% |
| Q4 25 | 14.3% | 11.8% | ||
| Q3 25 | 16.2% | 14.2% | ||
| Q2 25 | 22.2% | 14.7% | ||
| Q1 25 | 10.9% | 11.1% | ||
| Q4 24 | 14.2% | 8.5% | ||
| Q3 24 | 21.4% | 15.2% | ||
| Q2 24 | 21.7% | 15.2% | ||
| Q1 24 | 15.9% | 15.0% |
| Q4 25 | $0.90 | $2.20 | ||
| Q3 25 | $1.09 | $2.22 | ||
| Q2 25 | $1.41 | $2.29 | ||
| Q1 25 | $0.77 | $1.69 | ||
| Q4 24 | $0.98 | $1.41 | ||
| Q3 24 | $1.30 | $2.16 | ||
| Q2 24 | $1.34 | $2.14 | ||
| Q1 24 | $0.94 | $2.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $4.0B |
| Total DebtLower is stronger | $8.4B | — |
| Stockholders' EquityBook value | $15.5B | $22.4B |
| Total Assets | $31.6B | $47.8B |
| Debt / EquityLower = less leverage | 0.54× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $4.0B | ||
| Q3 25 | $1.2B | $3.3B | ||
| Q2 25 | $1.7B | $2.4B | ||
| Q1 25 | $1.2B | $2.3B | ||
| Q4 24 | $811.0M | $3.7B | ||
| Q3 24 | $645.0M | $3.9B | ||
| Q2 24 | $1.1B | $1.9B | ||
| Q1 24 | $1.1B | $2.3B |
| Q4 25 | $8.4B | — | ||
| Q3 25 | $8.4B | — | ||
| Q2 25 | $8.9B | — | ||
| Q1 25 | $8.9B | — | ||
| Q4 24 | $8.9B | — | ||
| Q3 24 | $8.9B | — | ||
| Q2 24 | $6.1B | — | ||
| Q1 24 | $6.1B | — |
| Q4 25 | $15.5B | $22.4B | ||
| Q3 25 | $15.3B | $21.8B | ||
| Q2 25 | $15.1B | $21.2B | ||
| Q1 25 | $14.5B | $20.9B | ||
| Q4 24 | $14.5B | $20.6B | ||
| Q3 24 | $14.3B | $20.1B | ||
| Q2 24 | $12.6B | $19.8B | ||
| Q1 24 | $12.2B | $19.2B |
| Q4 25 | $31.6B | $47.8B | ||
| Q3 25 | $31.2B | $47.1B | ||
| Q2 25 | $31.4B | $46.3B | ||
| Q1 25 | $30.9B | $46.0B | ||
| Q4 24 | $30.5B | $43.0B | ||
| Q3 24 | $30.3B | $43.8B | ||
| Q2 24 | $25.2B | $39.1B | ||
| Q1 24 | $25.0B | $39.4B |
| Q4 25 | 0.54× | — | ||
| Q3 25 | 0.55× | — | ||
| Q2 25 | 0.59× | — | ||
| Q1 25 | 0.61× | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.49× | — | ||
| Q1 24 | 0.51× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.5B | $2.1B |
| Free Cash FlowOCF − Capex | $702.0M | $1.9B |
| FCF MarginFCF / Revenue | 17.8% | 26.1% |
| Capex IntensityCapex / Revenue | 21.1% | 3.7% |
| Cash ConversionOCF / Net Profit | 2.73× | 2.52× |
| TTM Free Cash FlowTrailing 4 quarters | $3.1B | $4.3B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5B | $2.1B | ||
| Q3 25 | $1.7B | $1.5B | ||
| Q2 25 | $1.5B | $1.1B | ||
| Q1 25 | $1.9B | $250.0M | ||
| Q4 24 | $1.7B | $1.9B | ||
| Q3 24 | $1.7B | $1.5B | ||
| Q2 24 | $1.5B | $633.0M | ||
| Q1 24 | $1.7B | $204.0M |
| Q4 25 | $702.0M | $1.9B | ||
| Q3 25 | $820.0M | $1.4B | ||
| Q2 25 | $589.0M | $928.0M | ||
| Q1 25 | $1.0B | $127.0M | ||
| Q4 24 | $738.0M | $1.7B | ||
| Q3 24 | $786.0M | $1.3B | ||
| Q2 24 | $587.0M | $481.0M | ||
| Q1 24 | $844.0M | $37.0M |
| Q4 25 | 17.8% | 26.1% | ||
| Q3 25 | 19.3% | 22.3% | ||
| Q2 25 | 14.6% | 15.4% | ||
| Q1 25 | 22.2% | 2.2% | ||
| Q4 24 | 16.4% | 25.9% | ||
| Q3 24 | 20.7% | 23.7% | ||
| Q2 24 | 15.1% | 8.9% | ||
| Q1 24 | 22.6% | 0.7% |
| Q4 25 | 21.1% | 3.7% | ||
| Q3 25 | 20.5% | 3.1% | ||
| Q2 25 | 23.6% | 3.0% | ||
| Q1 25 | 20.5% | 2.1% | ||
| Q4 24 | 20.6% | 4.1% | ||
| Q3 24 | 23.1% | 3.1% | ||
| Q2 24 | 24.3% | 2.8% | ||
| Q1 24 | 23.9% | 3.2% |
| Q4 25 | 2.73× | 2.52× | ||
| Q3 25 | 2.46× | 1.79× | ||
| Q2 25 | 1.72× | 1.26× | ||
| Q1 25 | 3.93× | 0.38× | ||
| Q4 24 | 2.60× | 3.54× | ||
| Q3 24 | 2.05× | 1.77× | ||
| Q2 24 | 1.82× | 0.77× | ||
| Q1 24 | 2.92× | 0.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DVN
| Oil Gas And NGL Sales | $2.6B | 65% |
| Marketing And Midstream Revenues | $1.4B | 35% |
SYK
| Medical | $1.3B | 18% |
| Endoscopy | $1.1B | 16% |
| Traumaand Extremities | $1.1B | 15% |
| Instruments | $925.0M | 13% |
| Knees | $749.0M | 10% |
| Neuro Cranial | $669.0M | 9% |
| Neurovascular | $539.0M | 8% |
| Hips | $499.0M | 7% |
| Other Orthopaedics | $267.0M | 4% |
| Spine | $8.0M | 0% |
